Physician profile
Darcy Giger
NPI 1528090867
$683.09
in general payments reported to CMS, 2019-2025
15 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2021: $11.05 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $256.14 | 2019-2025 | Airsupra, Breztri |
| E.R. Squibb & Sons, L.L.C. | $111.76 | 2025 | Cobenfy |
| Glaxosmithkline, LLC. | $58.01 | 2019 | |
| Astellas Pharma US INC | $34.82 | 2019 | |
| Gilead Sciences, INC. | $34.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.40 | 2019 | |
| Pfizer INC. | $28.86 | 2019 | |
| Allergan, INC. | $22.91 | 2019 | |
| Amgen INC. | $21.24 | 2019 | |
| Sanofi Pasteur INC. | $17.00 | 2019 | |
| Genentech USA, INC. | $16.41 | 2019 | |
| Novo Nordisk INC | $14.23 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.18 | 2019 | |
| Abbvie INC. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darcy Giger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.